{
  "pmcid": "9808983",
  "sha256": "3abff4ea493f7979412d70664e9083816b756d08285ab6c34d0c7aa07465a533",
  "timestamp_utc": "2025-11-09T23:02:10.241158+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 12.175693215339233,
    "reading_ease": 30.13181907571291,
    "word_count": 226
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "A Randomised Controlled Trial of Closed-Loop Vasopressor Control in Post-Cardiac Surgery Patients"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants were randomised to either the CLV group or the control group"
      },
      "Participants": {
        "score": 1,
        "evidence": "40 patients admitted to the ICU after cardiac surgery"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised to either the CLV group or the control group, with norepinephrine infusion controlled by the CLV system or manually by ICU nurses, respectively"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study tested the hypothesis that CLV management reduces hypotension compared to standard care in postcardiac surgery patients."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the percentage of time with hypotension (MAP <65 mm Hg) over a 2-hour period."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using a computer-generated sequence, and allocation was concealed."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not applicable."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "40 patients admitted to the ICU after cardiac surgery"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The CLV group had significantly less hypotension (1.4% [0.9–2.3]) compared to the control group (12.5% [9.9–24.3]; location difference, −9.8% [95% CI, −5.4 to −15.9]; P < .001)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events occurred in either group."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: [Trial registration number]"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: [Source of funding]"
      }
    },
    "total_score": 15,
    "max_score": 25
  }
}